scholarly article | Q13442814 |
P2093 | author name string | Juan D Cañete | |
Julio Ramírez | |||
Raquel Celis | |||
Andrea Cuervo | |||
P2860 | cites work | Interleukin-17-positive mast cells contribute to synovial inflammation in spondylarthritis | Q85036491 |
Peripheral joint inflammation in early onset spondyloarthritis is not specifically related to enthesitis | Q86658107 | ||
Histologic evidence that mast cells contribute to local tissue inflammation in peripheral spondyloarthritis by regulating interleukin-17A content | Q90281185 | ||
Mast cells in early rheumatoid arthritis associate with disease severity and support B cell autoantibody production | Q91047208 | ||
Pathogenic stromal cells as therapeutic targets in joint inflammation | Q93017920 | ||
B lymphocyte autoimmunity in rheumatoid synovitis is independent of ectopic lymphoid neogenesis | Q94702098 | ||
Human mast cells capture, store, and release bioactive, exogenous IL-17A | Q95567806 | ||
A proposed classification of the immunological diseases | Q21144701 | ||
Infiltration of the synovial membrane with macrophage subsets and polymorphonuclear cells reflects global disease activity in spondyloarthropathy | Q24804272 | ||
Synovial histopathology of psoriatic arthritis, both oligo- and polyarticular, resembles spondyloarthropathy more than it does rheumatoid arthritis | Q24816628 | ||
What makes psoriatic and rheumatoid arthritis so different? | Q26778261 | ||
Immunopathology of synovitis: from histology to molecular pathways | Q26781647 | ||
Ectopic lymphoid neogenesis in rheumatic autoimmune diseases | Q30235935 | ||
Ectopic lymphoid structures support ongoing production of class-switched autoantibodies in rheumatoid synovium | Q33399862 | ||
Enthesitis in spondyloarthropathy | Q33690425 | ||
Comparative genomic profiling of synovium versus skin lesions in psoriatic arthritis | Q35522947 | ||
Comparative study of the synovial histology in rheumatoid arthritis, spondyloarthropathy, and osteoarthritis: influence of disease duration and activity | Q35549067 | ||
p53 expression in rheumatoid and psoriatic arthritis synovial tissue and association with joint damage | Q35555195 | ||
Analysis of IL-17(+) cells in facet joints of patients with spondyloarthritis suggests that the innate immune pathway might be of greater relevance than the Th17-mediated adaptive immune response | Q35557923 | ||
Detailed analysis of the cell infiltrate and the expression of mediators of synovial inflammation and joint destruction in the synovium of patients with psoriatic arthritis: implications for treatment | Q35638455 | ||
Ectopic lymphoid neogenesis is strongly associated with activation of the IL-23 pathway in rheumatoid synovitis | Q35834582 | ||
Ectopic lymphoid neogenesis in psoriatic arthritis | Q35953359 | ||
Intimal lining layer macrophages but not synovial sublining macrophages display an IL-10 polarized-like phenotype in chronic synovitis | Q36245798 | ||
Synovial cytokine expression in psoriatic arthritis and associations with lymphoid neogenesis and clinical features | Q36245883 | ||
Tofacitinib regulates synovial inflammation in psoriatic arthritis, inhibiting STAT activation and induction of negative feedback inhibitors | Q36475599 | ||
The concept of a "synovio-entheseal complex" and its implications for understanding joint inflammation and damage in psoriatic arthritis and beyond | Q36897200 | ||
Clinical Features and Diagnostic Considerations in Psoriatic Arthritis | Q38609814 | ||
Synovial vascular patterns and angiogenic factors expression in synovial tissue and serum of patients with rheumatoid arthritis | Q39746346 | ||
Synovial fibroblast hyperplasia in rheumatoid arthritis: clinicopathologic correlations and partial reversal by anti-tumor necrosis factor therapy | Q43434342 | ||
Disease-specific and inflammation-independent stromal alterations in spondylarthritis synovitis | Q44547443 | ||
Local synovial engagement of angiogenic TIE-2 is associated with the development of persistent erosive rheumatoid arthritis in patients with early arthritis | Q44588146 | ||
In situ analysis of interleukin-23- and interleukin-12-positive cells in the spine of patients with ankylosing spondylitis | Q45102170 | ||
Mast cells express IL-17A in rheumatoid arthritis synovium | Q46151437 | ||
Antiangiogenic effects of anti-tumor necrosis factor alpha therapy with infliximab in psoriatic arthritis | Q47596762 | ||
Diagnostic classification of spondylarthropathy and rheumatoid arthritis by synovial histopathology: a prospective study in 154 consecutive patients | Q49131512 | ||
Corrigendum: Synovial tissue research: a state-of-the-art review | Q49644356 | ||
Functionally distinct disease-associated fibroblast subsets in rheumatoid arthritis. | Q51767593 | ||
Angiopoietins, growth factors, and vascular morphology in early arthritis. | Q52860641 | ||
Macrophages from the synovium of active rheumatoid arthritis exhibit an activin A-dependent pro-inflammatory profile | Q58662234 | ||
Matrix metalloproteinase 9, apoptosis, and vascular morphology in early arthritis | Q59042887 | ||
Clinical significance of synovial lymphoid neogenesis and its reversal after anti-tumour necrosis factor therapy in rheumatoid arthritis | Q60915160 | ||
Diagnostic usefulness of synovial vascular morphology in chronic arthritis. A systematic survey of 100 cases | Q73589232 | ||
Characteristic magnetic resonance imaging entheseal changes of knee synovitis in spondylarthropathy. | Q74460386 | ||
Vascular changes in psoriatic knee joint synovitis | Q77170124 | ||
Distinct vascular patterns of early synovitis in psoriatic, reactive, and rheumatoid arthritis | Q77993356 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P407 | language of work or name | English | Q1860 |
P921 | main subject | synovitis | Q538432 |
Microarrays | Q57278040 | ||
P304 | page(s) | 14 | |
P577 | publication date | 2019-01-01 | |
P1433 | published in | Frontiers in Medicine | Q27726181 |
P1476 | title | Psoriatic Synovitis: Singularity and Potential Clinical Implications | |
P478 | volume | 6 |